loadpatents
Patent applications and USPTO patent grants for ZHONG; Pingyu.The latest application filed is for "il-1beta neutralizing human monoclonal antibodies".
Patent | Date |
---|---|
IL-1Beta Neutralizing Human Monoclonal Antibodies App 20210155686 - WANG; Cheng-I ;   et al. | 2021-05-27 |
IL-1Beta Neutralizing Human Monoclonal Antibodies App 20210155685 - WANG; Cheng-I ;   et al. | 2021-05-27 |
Method of reducing tumor growth with IL-1beta neutralizing human monoclonal antibodies Grant 10,919,962 - Wang , et al. February 16, 2 | 2021-02-16 |
Il-1beta Neutralizing Human Monoclonal Antibodies App 20210024627 - WANG; Cheng-I ;   et al. | 2021-01-28 |
Il-1beta Neutralizing Human Monoclonal Antibodies App 20190144535 - Wang; Cheng-l ;   et al. | 2019-05-16 |
IL-1.beta. neutralizing human monoclonal antibodies Grant 10,167,335 - Wang , et al. J | 2019-01-01 |
1B20 PCSK9 antagonists Grant 8,957,194 - Condra , et al. February 17, 2 | 2015-02-17 |
IL-1beta NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES App 20150037248 - Wang; Cheng-I ;   et al. | 2015-02-05 |
AX132 PCSK9 antagonists Grant 8,877,900 - Luo , et al. November 4, 2 | 2014-11-04 |
AX1 PCSK9 antagonists Grant 8,802,827 - Luo , et al. August 12, 2 | 2014-08-12 |
1d05 Pcsk9 Antagonists App 20140220027 - Condra; Jon H. ;   et al. | 2014-08-07 |
Methods For Diversifying Antibodies, Antibodies Derived Therefrom And Uses Thereof App 20140121123 - Wang; Kevin Caili ;   et al. | 2014-05-01 |
1D05 PCSK9 antagonists Grant 8,697,070 - Condra , et al. April 15, 2 | 2014-04-15 |
Eukaryotic cell display systems Grant 8,637,435 - Wang , et al. January 28, 2 | 2014-01-28 |
1b20 Pcsk9 Antagonists App 20130071379 - Condra; Jon H. ;   et al. | 2013-03-21 |
Eukaryotic Cell Display Systems App 20120329679 - Wang; Kevin Caili ;   et al. | 2012-12-27 |
1d05 Pcsk9 Antagonists App 20120301461 - Condra; Jon H. ;   et al. | 2012-11-29 |
Ax1 And Ax189 Psck9 Antagonists And Variants App 20120231005 - Luo; Peter Peizhi ;   et al. | 2012-09-13 |
Ax213 And Ax132 Psck9 Antagonists And Variants App 20120213794 - Luo; Peter Peizhi ;   et al. | 2012-08-23 |
1D05 PCSK9 antagonists Grant 8,188,234 - Condra , et al. May 29, 2 | 2012-05-29 |
1B20 PCSK9 antagonists Grant 8,188,233 - Condra , et al. May 29, 2 | 2012-05-29 |
Structure-Based Selection and Affinity Maturation of Antibody Library App 20120129702 - Luo; Peizhi ;   et al. | 2012-05-24 |
Anti-CD26 antibodies and methods of use thereof Grant 8,030,469 - Aoyagi , et al. October 4, 2 | 2011-10-04 |
Generation and affinity maturation of antibody library in silico App 20110124528 - Luo; Peizhi ;   et al. | 2011-05-26 |
Adaptor-directed helper systems Grant 7,910,350 - Wang , et al. March 22, 2 | 2011-03-22 |
Humanized antibodies against vascular endothelial growth factor Grant 7,667,004 - Zhong , et al. February 23, 2 | 2010-02-23 |
1D05 PCSK9 antagonists App 20090246192 - Condra; Jon H. ;   et al. | 2009-10-01 |
1b20 Pcsk9 Antagonists App 20090232795 - Condra; Jon H. ;   et al. | 2009-09-17 |
Eukaryotic cell display systems App 20090163379 - Wang; Kevin Caili ;   et al. | 2009-06-25 |
Anti-cd26 Antibodies And Methods Of Use Thereof App 20090136523 - Aoyagi; Teikichi ;   et al. | 2009-05-28 |
Cross-Species and Multi-Species Display Systems App 20090082221 - Wang; Kevin Caili ;   et al. | 2009-03-26 |
Anti-CD26 antibodies and methods of use thereof Grant 7,462,698 - Aoyagi , et al. December 9, 2 | 2008-12-09 |
Compositions and methods for generating chimeric heteromultimers Grant 7,429,652 - Wang , et al. September 30, 2 | 2008-09-30 |
Anti-CD26 antibodies and methods of use thereof App 20070105771 - Aoyagi; Teikichi ;   et al. | 2007-05-10 |
Generation and selection of protein library in silico App 20070037214 - Luo; Peizhi ;   et al. | 2007-02-15 |
Structure-based selection and affinity maturation of antibody library App 20070037217 - Luo; Peizhi ;   et al. | 2007-02-15 |
Adapter-directed display systems Grant 7,175,983 - Wang , et al. February 13, 2 | 2007-02-13 |
Adaptor-directed helper systems App 20060281181 - Wang; Caili ;   et al. | 2006-12-14 |
Structure-based selection and affinity maturation of antibody library Grant 7,117,096 - Luo , et al. October 3, 2 | 2006-10-03 |
Compositions and methods for generating chimeric heteromultimers App 20050009139 - Wang, Caili ;   et al. | 2005-01-13 |
Compositions and methods for generating chimeric heteromultimers Grant 6,833,441 - Wang , et al. December 21, 2 | 2004-12-21 |
Humanized antibodies against vascular endothelial growth factor App 20040133357 - Zhong, Pingyu ;   et al. | 2004-07-08 |
Generation and selection of protein library in silico App 20040010376 - Luo, Peizhi ;   et al. | 2004-01-15 |
Adapter-directed display systems App 20030104355 - Wang, Caili ;   et al. | 2003-06-05 |
Compositions and methods for generating chimeric heteromultimers App 20030027247 - Wang, Caili ;   et al. | 2003-02-06 |
Generation and affinity maturation of antibody library in silico App 20030022240 - Luo, Peizhi ;   et al. | 2003-01-30 |
Structure-based selection and affinity maturation of antibody library App 20020177170 - Luo, Peizhi ;   et al. | 2002-11-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.